Filter By Industry
Filter By Tag

Newsroom

SciTech Development LLC Press releases

1 - 10 of 10 Press Releases

Dec 23, 2019
The U.S. Food and Drug Administration (FDA) has accepted SciTech Development's Investigational New Drug (IND) Application for ST-001 nanoFenretinide, an experimental treatment for T-cell non-Hodgkin's lymphoma (NHL).

Dec 07, 2019
SciTech Development announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square.

Nov 22, 2019
SciTech Development is pleased to announce that it will be attending the J.P. Morgan Healthcare Conference January 12–16 in San Francisco, CA. SciTech will be participating in the BIO One-on-One Partnering™ @ JPM.

Oct 30, 2019
SciTech Development, a clinical stage drug development company, is pleased to announce that it has been invited to participate in the NYC Oncology Investor Conference 2019 at 1155 6th Ave 22nd Floor, New York, NY.

Oct 08, 2019
SciTech Development, a clinical stage drug development company, is pleased to announce that it will be presenting a poster at the 61st Annual American Society of Hematology (ASH) Meeting & Exposition in Orlando, Florida, December 7-10.

Sep 05, 2019
SciTech Development, a clinical stage drug development company, is pleased to announce that it has recently been awarded a foundation grant from a major, well-known cancer foundation for the scale-up, preparation and initiation of a Phase 1 clinical...

Sep 04, 2019
SciTech Development is pleased to announce that Nano Investments, LLC, a private equity firm from Rochester, Michigan has made a significant investment in SciTech via its Convertible Note Round (CNR) of funding.

Sep 03, 2019
SciTech Presenting at 2019 China BioMed Innovation and Investment Conference (CBIIC) SciTech Development, a clinical stage drug development company, is pleased to announce that it has been invited to give a presentation at the 2019 China BioMed...

Oct 27, 2018
(GROSSE POINTE FARMS, MI) - SciTech Development, a clinical stage drug development company, announced today that its President, Earle Holsapple, will deliver a corporate presentation and meet with investors at the NYC Oncology Investor Conference 2018.

Feb 06, 2018
SciTech's Oncology Drug Granted Orphan Status (GROSSE PONTE FARMS, MI) February 1, 2018 - SciTech Development is pleased to announce that the U.S.


SciTech Development LLC RSS Feed